Annals of Oncology Research and Therapy

REVIEW ARTICLE
Year
: 2022  |  Volume : 2  |  Issue : 1  |  Page : 10--16

Progress in multidisciplinary treatment of hemorrhagic radiation proctitis


Qiulian Li1, Guangjie Liao2 
1 Department of Gynecology, Red Cross Hospital of Yulin, Yulin, Guangxi, China
2 Department of Pathology, Red Cross Hospital of Yulin, Yulin, Guangxi, China

Correspondence Address:
Prof. Guangjie Liao
Department of Pathology, Red Cross Hospital of Yulin, No. 1, Jin Wang Rd. Yuzhou, Yulin, Guangxi
China

With the development and wide application of radiotherapy technology, the incidence of radiation proctitis (RP) caused by radiotherapy for pelvic malignant tumors tends to increase, especially the treatment of hemorrhagic RP (HRP) is very difficult. Complications such as intestinal necrosis and perforation cause great pain and inconvenience to patients. How to effectively and safely treat HRP is an urgent clinical problem to be solved. This article reviews the progress of multidisciplinary treatment of RP, especially HRP, in recent years, and focuses on the progress of formalin in the treatment of hemorrhagic radiation proctitis.


How to cite this article:
Li Q, Liao G. Progress in multidisciplinary treatment of hemorrhagic radiation proctitis.Ann Oncol Res Ther 2022;2:10-16


How to cite this URL:
Li Q, Liao G. Progress in multidisciplinary treatment of hemorrhagic radiation proctitis. Ann Oncol Res Ther [serial online] 2022 [cited 2022 Dec 2 ];2:10-16
Available from: http://www.aort.com/article.asp?issn=WKMP-0208;year=2022;volume=2;issue=1;spage=10;epage=16;aulast=Li;type=0